A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

As global equity markets expand, two corporate heavyweights are emerging as serious contenders to reach $1 trillion in market ...

CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

Rob Lowe opened up to PEOPLE about his late grandmother’s breast cancer journey and her success in a clinical trial. He’s now ...

Organizers of the march say their protest seeks to show solidarity with migrants and other groups that are being targeted by ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for pharmaceutical products — without naming the friend he was talking about.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

President Donald Trump said he plans to order a cut in prescription drug costs to bring them in line with other countries, ...